The National Medical Research Centre for EndocrinologyMoscow, Russia
The National Medical Research Centre for EndocrinologyMoscow, Russia.
Eur J Endocrinol. 2018 Apr;178(4):353-364. doi: 10.1530/EJE-17-0772. Epub 2018 Jan 26.
To evaluate the response of bone to chronic long-term growth hormone (GH) and insulin-like growth factor-1 (IGF1) excess by measuring the expression of selected mRNA and microRNA (miR) in bone tissue samples of patients with active acromegaly.
Case-control study.
Bone tissue samples were obtained during transsphenoidal adenomectomy from the sphenoid bone (sella turcica) from 14 patients with clinically and biochemically confirmed acromegaly and 10 patients with clinically non-functioning pituitary adenoma (NFPA) matched by sex and age. Expression of genes involved in the regulation of bone remodeling was studied using quantitative polymerase chain reaction (qPCR).
Of the genes involved in osteoblast and osteoclast activity, only alkaline phosphatase (ALP) mRNA was 50% downregulated in patients with acromegaly. GH excess caused increased expression of the Wnt signaling antagonists ( and agonists ( and changes in the levels of miR involved in mesenchymal stem cell commitment to chondrocytes (miR-199a-5p) or adipocytes (miR-27-5p, miR-125b-5p, miR-34a-5p, miR-188-3p) < 0.05; < 0.1. Relevant compensatory mechanisms were found through the changes in miR involved in osteoblastogenesis (miR-210-5p, miR-135a-5p, miR-211, miR-23a-3p, miR-204-5p), but the expression of TWIST1 was 50% downregulated and RUNX2 was unchanged.
Acromegaly had minimal effects on tested mRNAs specific to osteoblast or osteoclast function except for downregulated ALP expression. The expressions of miR known to be involved in mesenchymal stem cell commitment and downregulated TWIST1 expression suggest acromegaly has a negative effect on osteoblastogenesis.
通过测量活性肢端肥大症患者骨组织样本中选定的 mRNA 和 microRNA (miR) 的表达,评估慢性长期生长激素 (GH) 和胰岛素样生长因子-1 (IGF1) 过多对骨骼的反应。
病例对照研究。
从 14 例经临床和生化证实的肢端肥大症患者和 10 例性别和年龄匹配的临床无功能垂体腺瘤 (NFPA) 患者的蝶鞍蝶骨中经蝶窦腺瘤切除术获得骨组织样本。使用定量聚合酶链反应 (qPCR) 研究参与骨重塑调节的基因表达。
在参与成骨细胞和破骨细胞活性的基因中,只有碱性磷酸酶 (ALP) mRNA 在肢端肥大症患者中下调了 50%。GH 过多导致 Wnt 信号通路拮抗剂 ( 和激动剂 ( 的表达增加,并改变了参与间充质干细胞向软骨细胞 (miR-199a-5p) 或脂肪细胞 (miR-27-5p、miR-125b-5p、miR-34a-5p、miR-188-3p) 定向的 miR 水平 < 0.05; < 0.1。通过参与成骨细胞发生的 miR 的变化发现了相关的代偿机制 (miR-210-5p、miR-135a-5p、miR-211、miR-23a-3p、miR-204-5p),但 TWIST1 的表达下调了 50%,而 RUNX2 不变。
除了 ALP 表达下调外,肢端肥大症对成骨细胞或破骨细胞功能的特定测试 mRNAs 几乎没有影响。已知参与间充质干细胞定向和下调 TWIST1 表达的 miR 的表达表明,肢端肥大症对成骨细胞发生有负面影响。